{"version":"1.0","provider_name":"Press Arabia","provider_url":"https:\/\/pressarabia.qa","author_name":"admin","author_url":"https:\/\/pressarabia.qa\/author\/admin01\/","title":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"IDm7pssFFD\"><a href=\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\">SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/embed\/#?secret=IDm7pssFFD\" width=\"600\" height=\"338\" title=\"&#8220;SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT&#8221; &#8212; Press Arabia\" data-secret=\"IDm7pssFFD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta [\u2026]","thumbnail_url":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE="}